Wave Life Sciences Ltd. (CIK: 0001631574) EDGAR, Information, Filings... CompaniesBIO.Com

Wave Life Sciences Ltd.

Mailing address
733 CONCORD AVENUE, CAMBRIDGE, Singapore, 02138
Phone
617-949-2900
State location
Singapore
State of incorporation
Singapore
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Wave Life Sciences Ltd. (CIK: 0001631574) is an American company incorporated in the state of Singapore. Head office is located at 7 STRAITS VIEW, #12-00, MARINA ONE EAST TOWER, SINGAPORE, Singapore, 018936. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Wave Life Sciences Ltd. is a public company and trade via Over-The-Counter (OTC).

Old names:

Wave Life Sciences Pte Ltd from 2015-02-Feb to 2015-02-Nov

Owner	Filings	Transaction Date	Type of Owner
GSK PLC	0001131399	Jan-23-2023	10 percent owner
RA Capital Healthcare Fund LP	0001315082	Apr-01-2021	10 percent owner
RA CAPITAL MANAGEMENT, L.P.	0001346824	Apr-01-2021	director, 10 percent owner
Shah Rajeev M.	0001619841	Apr-01-2021	10 percent owner
Tan Aik Na	0001821285	Aug-18-2020	director
Gaiero David G	0001799784	Jan-09-2020	officer: Interim CFO
CORRIGAN MARK	0001250661	Sep-04-2019	director
Wagner Heidi L	0001655029	Sep-04-2019	director
Pott Amy	0001787363	Sep-04-2019	director
Baldry Mark	0001644137	Aug-05-2019	officer: Chief Commerical Officer
Kolchinsky Peter	0001384859	Aug-10-2017	director, 10 percent owner
Rawcliffe Adrian	0001555851	Feb-01-2017	director
HENRY CHRISTIAN O	0001263805	Nov-10-2016	director
Regnante Keith	0001682068	Aug-16-2016	officer: Chief Financial Officer
Panzara Michael A.	0001679039	Jul-11-2016	officer: Franchise Lead, Neurology
GUERCIOLINI ROBERTO	0001286837	Nov-10-2015	officer: See Remarks
Verdine Gregory L.	0001572315	Nov-10-2015	director
Vargeese Chandra	0001657675	Nov-10-2015	officer: See Remarks
Francis Chris	0001657709	Nov-10-2015	officer: See Remarks
BOLNO PAUL	0001657710	Nov-10-2015	director, officer: See Remarks
Moran Kyle	0001657765	Nov-10-2015	officer: See Remarks
Miura Koji	0001657766	Nov-10-2015	director
Wada Takeshi	0001657767	Nov-10-2015	director
TAKANASHI KEN	0001657768	Nov-10-2015	director, 10 percent owner
Kagoshima Shinsangyo Sousei Investment Limited Partnership	0001657769	Nov-10-2015	10 percent owner
Shin Nippon Biomedical Laboratories, Ltd.	0001657770	Nov-10-2015	10 percent owner
Tanaka Masaharu	0001657771	Nov-10-2015	director, 10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Wave Life Sciences Ltd.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001193125-26-009784 (34 Act) Size: KB	Jan-12-2026	001-37627 26524685
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-005195 ( Act) Size: 0 KB	Jan-06-2026
SCHEDULE 13D/A	Document	Acc-no: 0001346824-25-000072 (34 Act) Size: KB	Dec-15-2025	005-89180 251572394
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001999371-25-020336 ( Act) Size: 0 KB	Dec-15-2025
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-25-314747 (33 Act) Size: KB	Dec-11-2025	333-283122 251563365
8-K	Document	Current report filing Acc-no: 0001193125-25-314746 (34 Act) Size: KB	Dec-11-2025	001-37627 251563362
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314742 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314741 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314740 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314739 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314738 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314737 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314736 ( Act) Size: 0 KB	Dec-10-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-314735 ( Act) Size: 0 KB	Dec-10-2025
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-010006 (33 Act) Size: 0 KB	Dec-09-2025	001-37627 251559386
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-25-001177 (33 Act) Size: 0 KB	Dec-08-2025	001-37627 251557267
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-25-311383 (33 Act) Size: KB	Dec-08-2025	333-283122 251556856
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-009952 (33 Act) Size: 0 KB	Dec-08-2025	001-37627 251556598
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-009945 (33 Act) Size: 0 KB	Dec-08-2025	001-37627 251556571
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-009942 (33 Act) Size: 0 KB	Dec-08-2025	001-37627 251556562

Recent 20 filings. View all Wave Life Sciences Ltd. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Wave Life Sciences Ltd. overview
Wave Life Sciences Ltd. job
Wave Life Sciences Ltd. stock
Wave Life Sciences Ltd. ownership
Wave Life Sciences Ltd. CEO
Wave Life Sciences Ltd. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.